Migraine Drugs Market is estimated to be US$ 8.3 billion by 2030 with a CAGR of 15.70% during the forecast period

Other

Source: Migraine Drugs Market is estimated to be US$ 8.3 billion by 2030 with a CAGR of 15.70% during the forecast period

Migraine therapies are designed to alleviate symptoms or prevent future episodes in migraine sufferers. The rising frequency of migraines problems around the world, as well as increased awareness of novel drug classes, are driving the expansion of the migraine market. The introduction of calcitonin gene-related peptide (CGRP) is also predicted to boost the industry's growth. Migraine headaches are characterised by a strong and recurrent headache, as well as phonophobia, photophobia, and nausea.

---